Instadeep, a Tunisian-born Artificial Intelligence (AI) startup is to be acquired by Biopharmaceutical New Technologies (BioNTech) a next generation immunotherapy company for £562 million. The transaction includes a total upfront consideration of approximately £362 million in cash and BioNTech shares to acquire 100% of the remaining InstaDeep shares, excluding the shares already owned by BioNTech. … Continue reading German bio-tech firm BioNTech acquires Tunisian-born AI startup, Instadeep, for £562 million